Exosome Therapy: Questions and Answers

No. The FDA has not approved any exosome product.

The agency's public safety notification of December 6, 2019 states that there are currently no FDA-approved exosome products. It adds that exosomes used to treat diseases and conditions in humans are regulated as drugs and biological products, which need premarket review and approval. We opened the notice on October 15, 2026, and the page is still marked as current as of December 6, 2019, so we cannot say from the page whether the FDA has said more since.

The FDA status guide walks through the notice, the warning letters and the device rules.

Some microneedling devices carry FDA clearance for specific uses, and clearance is a different step from approval. In the 510(k) letter K241400, dated August 29, 2024, one prescription-use device is cleared to improve the look of wrinkles of the neck (Fitzpatrick skin types II to IV) and of facial acne scars in adults aged 22 and older.

The clearance is about the device. The regulation that classifies these devices leaves out devices intended to deliver cosmetics, drugs or biologics through the skin, so we read the clearance as not covering the product placed on the skin.

Nobody can say yes for every product and every person. The risks that are best documented belong to the device step: in a review of 85 microneedling articles, redness, swelling, pain and dry skin or peeling were expected for up to 7 days, and some people had lasting pigment change, tram-track scarring or granulomatous reactions.

The exosome product adds unknowns, because its contents and sources vary. No exosome product is FDA approved. See the safety guide for who should avoid it and what to ask a clinic.

For microneedling: transient redness and swelling, pain, dry skin and peeling, pigment change, swollen lymph nodes and irritant contact dermatitis. Higher risk went with active infection, darker skin and metal allergy.

For exosome products, the FDA's 2019 notice describes serious adverse events in patients who received unapproved products marketed as containing exosomes, and a 2026 review mentions reports of adverse reactions with unapproved products sold as exosome-based. Report problems through the FDA's MedWatch program.

In our survey of 13 providers in 11 US metro areas on October 16, 2026, we recorded the price of a single exosome microneedling facial and report the median, the middle half and the full range. Not all of the businesses are medical clinics.

The cost guide shows the table and lists what a quote should include and what to ask for in writing, so you can compare clinics yourself.

None of the sources we cite sets a standard. The protocols differ: one trial of a laser with a topical exosome-mimetic product and a polynucleotide gave three treatments inside four weeks and checked results at three months, and another trial checked at weeks 4 and 12. A clinic's plan is its own, so ask for the number of sessions, the spacing and the total price in writing.

None of the sources we cite shows it. The 2026 reviews describe short-term effects and ask for longer follow-up. Skin also changes over time with or without a treatment. Be wary of anyone who promises a fixed or lasting result.

The evidence is preliminary. Small studies report short-term changes in measures such as hydration, texture, pores and wrinkle scores. Many of the studies are not randomized, some include work in animals, and follow-up is short.

The study table lists each study with its size, what it measured and its limits.

PRP comes from the patient's own blood. Exosome products come from other biological sources, and their contents and quality vary between products. The PRP review we cite asks for standard preparation protocols, and the exosome reviews ask for longer and larger studies.

None of the studies we cite compares the two, so none ranks them. See the comparison.

Studies pair them, and clinics may offer the pairing. For the FDA the two stay separate: a device may be cleared for particular uses, and no exosome product is approved. A 2021 safety review advised caution when microneedling is used with products not intended to be applied with microneedles.

Details are in the microneedling guide.

"Not approved" does not mean "banned", and it does not mean "safe". The FDA decides by what a product is intended to do and how it is sold. It has sent warning letters to companies selling exosome products; in one dated December 30, 2024, it called three products from one company unapproved new drugs and unlicensed biological products.

Cosmetics can be sold without FDA approval when the claims stay cosmetic. We cannot say whether a given product or clinic is lawful. Ask the clinic under what rules it uses its product.

We do not list clinics by city. Start with the state licensing board that covers the person who would treat you, and check the license and any disciplinary history. Ask which product they use, who makes it and what documents they can show, and ask for a written quote.

The home page has a short checklist, and our own checks are public.

We advise against it. The clinic procedure uses a device operated by a licensed professional. Over-the-counter exosome products are skincare, which is a different thing. Do not combine a consumer product with needling at home.

No. They are skincare products whose labels may list exosomes, and we cannot verify the amount or the source. Our label guide shows how to read one, using three makers' own pages.

Today it does not. A partner clinic may compensate us in the future, and we may join product affiliate programs later. If that happens, the page with the link will say so before the first link, and our disclosure page will list it.